Home » ZS Pharma Reports Phase III Trial Results of Hyperkalemia Drug
ZS Pharma Reports Phase III Trial Results of Hyperkalemia Drug
ZS Pharma has released the results of a Phase III trial of its ZS-003 hyperkalemia drug. The drug met its endpoint for reducing potassium.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May